nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—ABCG2—Topotecan—cervical cancer	0.69	0.735	CbGbCtD
Sumatriptan—ABCB1—Topotecan—cervical cancer	0.249	0.265	CbGbCtD
Sumatriptan—Intestinal obstruction—Topotecan—cervical cancer	0.00189	0.0539	CcSEcCtD
Sumatriptan—Neuralgia—Topotecan—cervical cancer	0.00185	0.0528	CcSEcCtD
Sumatriptan—SLCO1B1—renal system—cervical cancer	0.00155	0.0604	CbGeAlD
Sumatriptan—Dysmenorrhoea—Topotecan—cervical cancer	0.00141	0.0404	CcSEcCtD
Sumatriptan—Pulmonary embolism—Topotecan—cervical cancer	0.00129	0.0367	CcSEcCtD
Sumatriptan—SLCO1A2—renal system—cervical cancer	0.00126	0.0491	CbGeAlD
Sumatriptan—SLCO1B1—female reproductive system—cervical cancer	0.00124	0.0484	CbGeAlD
Sumatriptan—Colitis—Topotecan—cervical cancer	0.00124	0.0352	CcSEcCtD
Sumatriptan—Ear pain—Topotecan—cervical cancer	0.00109	0.0312	CcSEcCtD
Sumatriptan—HTR1A—renal system—cervical cancer	0.00108	0.0422	CbGeAlD
Sumatriptan—HTR1B—female reproductive system—cervical cancer	0.00107	0.0418	CbGeAlD
Sumatriptan—MAOA—uterine cervix—cervical cancer	0.00106	0.0412	CbGeAlD
Sumatriptan—HTR1D—female reproductive system—cervical cancer	0.00104	0.0405	CbGeAlD
Sumatriptan—MAOA—decidua—cervical cancer	0.00101	0.0392	CbGeAlD
Sumatriptan—MAOA—renal system—cervical cancer	0.000988	0.0385	CbGeAlD
Sumatriptan—Dermatitis bullous—Topotecan—cervical cancer	0.000977	0.0279	CcSEcCtD
Sumatriptan—Anaphylactoid reaction—Topotecan—cervical cancer	0.000965	0.0275	CcSEcCtD
Sumatriptan—MAOA—endometrium—cervical cancer	0.000955	0.0372	CbGeAlD
Sumatriptan—MAOA—mammalian vulva—cervical cancer	0.000924	0.036	CbGeAlD
Sumatriptan—ABCG2—uterine cervix—cervical cancer	0.000915	0.0357	CbGeAlD
Sumatriptan—MAOA—uterus—cervical cancer	0.00088	0.0343	CbGeAlD
Sumatriptan—ABCG2—decidua—cervical cancer	0.000872	0.034	CbGeAlD
Sumatriptan—Cramp muscle—Topotecan—cervical cancer	0.000841	0.024	CcSEcCtD
Sumatriptan—ABCG2—endometrium—cervical cancer	0.000828	0.0323	CbGeAlD
Sumatriptan—ABCG2—mammalian vulva—cervical cancer	0.000801	0.0312	CbGeAlD
Sumatriptan—MAOA—female reproductive system—cervical cancer	0.000791	0.0308	CbGeAlD
Sumatriptan—Pancytopenia—Topotecan—cervical cancer	0.000767	0.0219	CcSEcCtD
Sumatriptan—ABCG2—uterus—cervical cancer	0.000763	0.0297	CbGeAlD
Sumatriptan—Weight increased—Topotecan—cervical cancer	0.000735	0.021	CcSEcCtD
Sumatriptan—MAOA—female gonad—cervical cancer	0.00072	0.0281	CbGeAlD
Sumatriptan—MAOA—vagina—cervical cancer	0.000715	0.0279	CbGeAlD
Sumatriptan—Sweating—Topotecan—cervical cancer	0.00069	0.0197	CcSEcCtD
Sumatriptan—Epistaxis—Topotecan—cervical cancer	0.000679	0.0194	CcSEcCtD
Sumatriptan—Haemoglobin—Topotecan—cervical cancer	0.000649	0.0185	CcSEcCtD
Sumatriptan—Haemorrhage—Topotecan—cervical cancer	0.000646	0.0184	CcSEcCtD
Sumatriptan—Hypoaesthesia—Topotecan—cervical cancer	0.000643	0.0183	CcSEcCtD
Sumatriptan—ABCG2—female gonad—cervical cancer	0.000624	0.0243	CbGeAlD
Sumatriptan—ABCG2—vagina—cervical cancer	0.00062	0.0242	CbGeAlD
Sumatriptan—Angiopathy—Topotecan—cervical cancer	0.000586	0.0167	CcSEcCtD
Sumatriptan—Immune system disorder—Topotecan—cervical cancer	0.000584	0.0167	CcSEcCtD
Sumatriptan—Mediastinal disorder—Topotecan—cervical cancer	0.000582	0.0166	CcSEcCtD
Sumatriptan—Chills—Topotecan—cervical cancer	0.00058	0.0165	CcSEcCtD
Sumatriptan—Back pain—Topotecan—cervical cancer	0.000544	0.0155	CcSEcCtD
Sumatriptan—Muscle spasms—Topotecan—cervical cancer	0.000541	0.0154	CcSEcCtD
Sumatriptan—Ill-defined disorder—Topotecan—cervical cancer	0.000522	0.0149	CcSEcCtD
Sumatriptan—Anaemia—Topotecan—cervical cancer	0.00052	0.0148	CcSEcCtD
Sumatriptan—Angioedema—Topotecan—cervical cancer	0.000514	0.0147	CcSEcCtD
Sumatriptan—Malaise—Topotecan—cervical cancer	0.000507	0.0145	CcSEcCtD
Sumatriptan—Cough—Topotecan—cervical cancer	0.000491	0.014	CcSEcCtD
Sumatriptan—Chest pain—Topotecan—cervical cancer	0.000479	0.0137	CcSEcCtD
Sumatriptan—Myalgia—Topotecan—cervical cancer	0.000479	0.0137	CcSEcCtD
Sumatriptan—Arthralgia—Topotecan—cervical cancer	0.000479	0.0137	CcSEcCtD
Sumatriptan—Discomfort—Topotecan—cervical cancer	0.000473	0.0135	CcSEcCtD
Sumatriptan—MAOA—lymph node—cervical cancer	0.000463	0.018	CbGeAlD
Sumatriptan—Anaphylactic shock—Topotecan—cervical cancer	0.000459	0.0131	CcSEcCtD
Sumatriptan—Infection—Topotecan—cervical cancer	0.000456	0.013	CcSEcCtD
Sumatriptan—ABCB1—epithelium—cervical cancer	0.000455	0.0177	CbGeAlD
Sumatriptan—ABCB1—uterine cervix—cervical cancer	0.000451	0.0176	CbGeAlD
Sumatriptan—Nervous system disorder—Topotecan—cervical cancer	0.00045	0.0128	CcSEcCtD
Sumatriptan—Thrombocytopenia—Topotecan—cervical cancer	0.000449	0.0128	CcSEcCtD
Sumatriptan—Skin disorder—Topotecan—cervical cancer	0.000446	0.0127	CcSEcCtD
Sumatriptan—Hyperhidrosis—Topotecan—cervical cancer	0.000444	0.0127	CcSEcCtD
Sumatriptan—ABCB1—decidua—cervical cancer	0.00043	0.0168	CbGeAlD
Sumatriptan—ABCB1—renal system—cervical cancer	0.000422	0.0165	CbGeAlD
Sumatriptan—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000418	0.0119	CcSEcCtD
Sumatriptan—Paraesthesia—Topotecan—cervical cancer	0.000412	0.0118	CcSEcCtD
Sumatriptan—Dyspnoea—Topotecan—cervical cancer	0.000409	0.0117	CcSEcCtD
Sumatriptan—ABCB1—endometrium—cervical cancer	0.000408	0.0159	CbGeAlD
Sumatriptan—ABCG2—lymph node—cervical cancer	0.000401	0.0156	CbGeAlD
Sumatriptan—Decreased appetite—Topotecan—cervical cancer	0.000399	0.0114	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Topotecan—cervical cancer	0.000396	0.0113	CcSEcCtD
Sumatriptan—Fatigue—Topotecan—cervical cancer	0.000396	0.0113	CcSEcCtD
Sumatriptan—ABCB1—mammalian vulva—cervical cancer	0.000395	0.0154	CbGeAlD
Sumatriptan—Constipation—Topotecan—cervical cancer	0.000393	0.0112	CcSEcCtD
Sumatriptan—Pain—Topotecan—cervical cancer	0.000393	0.0112	CcSEcCtD
Sumatriptan—Feeling abnormal—Topotecan—cervical cancer	0.000378	0.0108	CcSEcCtD
Sumatriptan—ABCB1—uterus—cervical cancer	0.000376	0.0147	CbGeAlD
Sumatriptan—Gastrointestinal pain—Topotecan—cervical cancer	0.000375	0.0107	CcSEcCtD
Sumatriptan—Urticaria—Topotecan—cervical cancer	0.000365	0.0104	CcSEcCtD
Sumatriptan—Abdominal pain—Topotecan—cervical cancer	0.000363	0.0104	CcSEcCtD
Sumatriptan—Body temperature increased—Topotecan—cervical cancer	0.000363	0.0104	CcSEcCtD
Sumatriptan—Hypersensitivity—Topotecan—cervical cancer	0.000338	0.00965	CcSEcCtD
Sumatriptan—ABCB1—female reproductive system—cervical cancer	0.000338	0.0132	CbGeAlD
Sumatriptan—Asthenia—Topotecan—cervical cancer	0.000329	0.0094	CcSEcCtD
Sumatriptan—Pruritus—Topotecan—cervical cancer	0.000325	0.00927	CcSEcCtD
Sumatriptan—Diarrhoea—Topotecan—cervical cancer	0.000314	0.00896	CcSEcCtD
Sumatriptan—ABCB1—female gonad—cervical cancer	0.000308	0.012	CbGeAlD
Sumatriptan—ABCB1—vagina—cervical cancer	0.000306	0.0119	CbGeAlD
Sumatriptan—Dizziness—Topotecan—cervical cancer	0.000304	0.00866	CcSEcCtD
Sumatriptan—Vomiting—Topotecan—cervical cancer	0.000292	0.00833	CcSEcCtD
Sumatriptan—Rash—Topotecan—cervical cancer	0.000289	0.00826	CcSEcCtD
Sumatriptan—Dermatitis—Topotecan—cervical cancer	0.000289	0.00825	CcSEcCtD
Sumatriptan—Headache—Topotecan—cervical cancer	0.000288	0.0082	CcSEcCtD
Sumatriptan—Nausea—Topotecan—cervical cancer	0.000273	0.00778	CcSEcCtD
Sumatriptan—ABCB1—lymph node—cervical cancer	0.000198	0.00771	CbGeAlD
